We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nmc Health Plc | LSE:NMC | London | Ordinary Share | GB00B7FC0762 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 938.40 | 940.00 | 941.60 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/8/2019 08:13 | https://www.londonst | simonandrews981 | |
05/8/2019 07:25 | interesting announcement this morning! Major shareholder of NMC has released 6,635,294 ordinary shares previously pledged. Taking this positively | jredd | |
01/8/2019 15:11 | Went sharply better as you made your post!.....spooky. | steeplejack | |
01/8/2019 13:50 | I'm short these & it's paying nicely.............f Stop at 2400p to protect profits. Take profit at 2250p. Now 2382p. | napoleon 14th | |
30/7/2019 19:13 | https://www.fool.co. | simonandrews981 | |
30/7/2019 06:15 | Zacks investment research upgrades NMC health from a sell rating to a hold rating. | robertsjake130 | |
28/7/2019 23:39 | I think I'm adding another 290k to my portfolio | terrysmith1 | |
28/7/2019 13:12 | Barclays issues another report Friday reaffirming NMC as one of its tops picks after a visit to Saudi Arabia to view NMC's assets and progress. A very positive report with a main focus on fundamentals. Barclays price target is 41 pounds. Definitely buying more tomorrow. | robertsjake130 | |
26/7/2019 10:13 | Thanks for this. Bought a chunk more on Monday that has brought me out of the red. The Times assessment has convinced me not to now reduce to a more cautious sized holding, but wait a bit longer to see if these are now back on an upward trajectory. | scooper72 | |
25/7/2019 12:17 | 608k shares traded at 25 today on NMC which represents 0.5% of float and 136% of 20 day volume. Positive momentum | jredd | |
24/7/2019 09:12 | Hopefully the Goldmans buy reaffirmation will squeeze the shorts.(AQR haven't upped their short of 3.31% for a month). | steeplejack | |
24/7/2019 08:39 | PT by banks JP Morgan 43, Bank of America 39, HSBC 46, barclays 41, berenberg 36. performance of last 5 days and viewing technical analysis looks like a strong rally is coming. I feel like bulls are winning this time. | jredd | |
23/7/2019 12:13 | So how can Jeffries and gs be so far apart??? Gs are long Jeffries are short | limay | |
23/7/2019 07:34 | 44 squids would be nice - did GS give a time line? | johnrxx99 | |
22/7/2019 10:09 | Goldman Sachs reiterates it's buy recommendation after meeting management with a price target of 44.90 and an upside of nearly 100% from today's price. The next catalyst will be results and soon it's going to be an ugly squeeze for all the shorters out there. | robertsjake130 | |
18/7/2019 18:09 | https://www.thetimes | jredd | |
16/7/2019 20:02 | Jefferies report has thrown lots of negativities including corporate governance issues, related party transactions, opaqueness in accounting, supply chain finance, high leverage etc. These points clearly depict serious shortcomings in the way the company is operating. If these are indeed existing, then this company is going to join the ranks of carillon, BHS, Abrraj etc. It's time to exercise caution on this stock till the picture is clear. One thing I am not able to understand till date is how NMC records growth in all aspects when the whole region is witnessing a downturn and it's peers in the same industry is reporting negative growth. Maybe they have magic to re-engineer their numbers. Innovative accounting! | johnferro1 | |
10/7/2019 22:37 | Jeffries has released its latest report reiterating underperform for the stock with the PT slashed down to GBP 1986. Looks like the stock is going to be range bound in the near term. Shorts will be active so long the key shareholders fails to release the shares pledged. Can’t understand why the key shareholders are delaying the release of the shares pledged given their deep pockets. It’s advisable to stay off this stock for the time being. | johnferro1 | |
10/7/2019 18:31 | Anyone have any intel. on this one? rising shorts seemed to have hit a plateau, are they all on holiday in Marbella? this is the latest i can find. Hard for me to not want to buy at these levels but obviously the short numbers are a little off putting "(NMC) has plunged as short sellers targeted the company amid concern its governance is lacking, it’s taken on too much debt for acquisitions and its accounting is too opaque." - | gimpdaddyy | |
13/6/2019 12:17 | Ex div today 18.1p | hjs | |
13/6/2019 10:55 | If all the reports are correct that I have seen, at the current price NMC is extremely attractive | terrysmith1 | |
12/6/2019 22:27 | But mkt is saying something else. On a yellow card for me now. | aishah | |
12/6/2019 22:26 | "UAE-based healthcare provider NMC Health (NMC) tops the list with a staggeringly high earnings growth rate and a surprisingly large discount to its previous price-high. The fact that it is slightly more expensive than the average stock on a forward earnings basis is neither here nor there in our book."Comment from Share Magazine back on 6 June.Article was looking at valuations and the NMC comment concluded a review of high and low ratings currently afforded to large cap stocks.Looks like Share Magazine regards the rating currently suffered by NMC to be somewhat anomalous......and we all agree. | steeplejack | |
11/6/2019 09:01 | Yes there is a CGT liability on CFD gains.Thus,there are higher than normal commission charges,accumulating finance charges and possible CGT payable (unlike spreadbetting).In fact,quite why I have a CFD account is far from obvious!Anyway,NMC heading for two days of gains.Exciting. | steeplejack |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions